Wang WY - Search Results

1

Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.

Lin JC, Wang WY, Liang WM, Chou HY, Jan JS, Jiang RS, Wang JY, Twu CW, Liang KL, Chao J, Shen WC. Lin JC, et al. Among authors: wang jy, wang wy. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1342-8. doi: 10.1016/j.ijrobp.2007.02.012. Epub 2007 Apr 20. Int J Radiat Oncol Biol Phys. 2007. PMID: 17449194 Clinical Trial.

2

Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.

Lin JC, Chen KY, Wang WY, Jan JS, Liang WM, Wei YH. Lin JC, et al. Among authors: wang wy. Int J Cancer. 2002 Feb 1;97(4):548-53. doi: 10.1002/ijc.10075. Int J Cancer. 2002. PMID: 11802221

3

PCR detection of circulating tumor cells in nasopharyngeal carcinoma patients with distant metastasis: effect of enzyme and sampling.

Lin JC, Chen KY, Wang WY, Jan JS, Wei YH. Lin JC, et al. Among authors: wang wy. Head Neck. 2002 Jun;24(6):591-6. doi: 10.1002/hed.10102. Head Neck. 2002. PMID: 12112557

4

Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma.

Wang WY, Chien YC, Jan JS, Chueh CM, Lin JC. Wang WY, et al. Clin Cancer Res. 2002 Aug;8(8):2586-90. Clin Cancer Res. 2002. PMID: 12171888

5

Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.

Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Lin JC, et al. Among authors: wang wy. J Clin Oncol. 2003 Feb 15;21(4):631-7. doi: 10.1200/JCO.2003.06.158. J Clin Oncol. 2003. PMID: 12586799 Clinical Trial.

6

Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.

Lin JC, Jan JS, Chen KY, Hsu CY, Liang WM, Wang WY. Lin JC, et al. Among authors: wang wy. Head Neck. 2003 Jun;25(6):438-50. doi: 10.1002/hed.10238. Head Neck. 2003. PMID: 12784235

7

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma.

Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS, Jiang RS. Lin JC, et al. Among authors: wang wy. N Engl J Med. 2004 Jun 10;350(24):2461-70. doi: 10.1056/NEJMoa032260. N Engl J Med. 2004. PMID: 15190138 Free article.

8

Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.

Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC. Twu CW, et al. Among authors: wang wy. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):130-7. doi: 10.1016/j.ijrobp.2006.07.012. Epub 2006 Sep 18. Int J Radiat Oncol Biol Phys. 2007. PMID: 16979842

9

Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma.

Wang WY, Twu CW, Chen HH, Jan JS, Jiang RS, Chao JY, Liang KL, Chen KW, Wu CT, Lin JC. Wang WY, et al. Clin Cancer Res. 2010 Feb 1;16(3):1016-24. doi: 10.1158/1078-0432.CCR-09-2796. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103659

10

Plasma Epstein-Barr virus DNA screening followed by ¹⁸F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma.

Wang WY, Twu CW, Lin WY, Jiang RS, Liang KL, Chen KW, Wu CT, Shih YT, Lin JC. Wang WY, et al. Cancer. 2011 Oct 1;117(19):4452-9. doi: 10.1002/cncr.26069. Epub 2011 Mar 22. Cancer. 2011. PMID: 21437892 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,173 results

Search Page

Filters